Non-members: Click here to review a complimentary excerpt from “Best Practices in Scientific Publications Strategy: Alignment and Effectiveness”
Bio-pharmaceutical organizations rely on scientific publications to inform the medical community about critical clinical trial data. With growing calls for transparency and data disclosure, global publications leaders find themselves in a balancing act—ensuring both scientific credibility and commercial viability.
Best Practices, LLC undertook benchmarking research to investigate how top pharmaceutical and biotechnology companies shape their global scientific publication strategies and plans to maintain credibility in the scientific community and deliver publications that drive brand success. In particular, this study provides benchmarks around publication strategy creation and data delivery, publication channel utilization across product lifecycle; and measuring publication effectiveness.
- Transition of Global Publications from Commercial to Clinical
- Publication Plan Strategy and Delivery
- Publication Content and Channels
- Measuring Publication Effectiveness
- Tactics to Communicate and Implement Publications Strategy with Key Stakeholders across the Organization
- Changes in Publication Activities in Specific Areas
- Delivery of Publication Plan
- Regional Affiliates’ Publication Plan
- How to Ensure Alignment among the Regional and Global Plans
- Most Effective Publication Vehicles and Content Types for Publications at Each Phase of the Product Lifecycle
- Important Target Audience for Publications at Each Phase of the Product Lifecycle
- Medical Publication Strategy Development Stage
- Last Stage for Involvement of the Publication Function
- First Stage of Publishing an Abstract and a Manuscript
- Publishing Output 2016 - Total Number of Publications, Abstracts and Manuscripts Produced
- Total Number of Publications (by Type) Required During the Phase 3 to Launch Period for Market Entry
- Mix of Publication Papers Appearing in Each of Three-tiers of Publications During Phase 3 to Launch Period
- Important Channels for Publishing Clinical Results
- Effective Measures to Evaluate Publication Management Program
SAMPLE KEY FINDINGS
- Outsourcing on the Rise for Publication Plan Delivery: Eighty percent of study participants outsource some portion of the delivery of their publication plan. Outsourcing has grown in the last five years as a core strategy of publication plan delivery. In our 2011 study, 47% of companies handled all delivery work in-house, whereas only 5% did so in 2016.
Best Practices, LLC engaged 20 leaders from 19 leading bio-pharmaceutical companies with direct experience working in scientific publishing. Almost 75% of participants are from the U.S. region.